Jason Hou, MD, on Newer and Emerging Therapeutic Targets

Dr Hou discusses his presentation on new therapeutic agents in development for treatment of IBD, from the September 26 virtual Advances in Inflammatory Bowel Disease regional meeting.

Additional Resources:

AIBD newsroom

For more information about AIBD 2020 and to register for the AIBD Annual Meeting in December, visit https://www.advancesinibd.com

Jason Hou, MD, is an associate professor of medicine and gastroenterologist from Baylor College of Medicine in Houston, Texas.

Submit Feedback

Name